glp-1 and tinnitus Risk of Hearing Loss in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists Sodium–Glucose Cotransporter 2 Inhibitors Risk of peripheral vestibular disorders

Cell 79 , 812823 (2020)

Because tirzepatide activates two pathways instead of one, some patients experience slightly stronger initial GI effects, though this does not necessarily mean worse tolerabilitymany adapt quickly and report manageable symptoms

Zepbound is approved for adults with obesity, or adults who are overweight and have at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol

A study specifically measuring ALCARs safety for elderly patients also found that it can be taken without significant side effects (17)

Avoid Unnecessary Additives Finally, its wise to avoid supplements with unnecessary fillers and artificial ingredients

For an overview of how regulators view this market, see our medical disclaimer